Search | מנבטים ניהול ביטחון

Workin Dbmr added blog אחר
2026-07-07 05:16:29 -

Could Precision Oncology Advance the Topoisomerase Inhibitors Market
According to the latest report published by Data Bridge Market Research, the Topoisomerase Inhibitors Market CAGR Value The global topoisomerase inhibitors market size was valued at USD 5.49 billion in 2025 and is expected to reach USD 8.17 billion by 2033, at a CAGR of 5.10% during the forecast period Salient attributes used while forming an influential Topoisomerase Inhibitors...

0 Comments 0 Shares

Please log in to like, share and comment!
Kajal Khomane added blog אחר
2026-07-07 12:02:58 -

First-in-Class Oncology Drug Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook
" According to the latest report published by Data Bridge Market Research, the First-in-Class Oncology Drug Market The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery...

0 Comments 0 Shares

Please log in to like, share and comment!
Workin Dbmr added blog אחר
2026-07-21 05:55:27 -

What Is Driving Innovation in the Hormone-Refractory Oncology Drug Market?
According to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period This Hormone-Refractory Oncology Drug Market research...

0 Comments 0 Shares

Please log in to like, share and comment!
Workin Dbmr added blog אחר
2026-07-23 04:23:35 -

How Is the Tumor Markers Testing Market Improving Early Cancer Detection?
According to the latest report published by Data Bridge Market Research, the Tumor Markers Testing Market CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow...

0 Comments 0 Shares

Please log in to like, share and comment!